Capmatinib

Cat. No.: PI1029712808

Description: Capmatinib is an orally bioavailable, adenosine triphosphate (ATP)- selective inhibitor of the MET tyrosine kinase domain that inhibits downstream signaling and subsequent tumor growth and progression.

Product Details

CAS	1029712-80-8
Trade Names	Tabrecta
Molecular Formula	C23H17FN6O
Molecular Weight	412.4
Available Formulations	Oral Solid
Technology	Synthetic

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *

For product and service inquiries, please use our online system or send an email to .